MiR-1 overexpression could improve the cis-platinum sensitivity of NSCLC cells by reducing the expression of ATG3, causing impaired ATG3-mediated autophagy, which provides a potential target for relieving antitumor drug resistance (Hua et al., 2018). This evidence concerns the gene ATG3 and non-small cell lung carcinoma.